AIF1 and COVID-19: The study by Serrano G.E. et al. showed that the area occupied by Iba-1-positive microglia was significantly reduced in the amygdala and cerebellum of COVID-19 deceased patients, while no changes were detected in LN3-labeled (“activated”) microglia.